ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BRUCE SILVER MD

Geriatric Medicine

4,916

$245K

180
171 are 65+

21%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

IRA SHARP M.D.

Geriatric Medicine

7,439

$406K

383
325 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

LESLEY CARSON MD

Geriatric Medicine

6,845

$298K

325
311 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

3%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

WILLIAM GIBBONS MD

Geriatric Medicine

10,078

$572K

454
419 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

MATTHEW COPPOLA M.D.

Geriatric Medicine

15,298

$703K

480
450 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

15%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

BOHDAN MARTYNEC M.D.

Geriatric Medicine

13,836

$877K

672
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

SUPRIYO GHOSH MD

Geriatric Medicine

8,955

$599K

526
471 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

JAY ELDER M.D.

Geriatric Medicine

16,412

$902K

529
438 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

HARRY HUTCHINSON DO

Geriatric Medicine

14,326

$823K

519
471 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

KARL SCHWABE MD

Geriatric Medicine

9,498

$510K

423
360 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $50

MELANIE JEWELL MD

Geriatric Medicine

12,055

$715K

637
545 are 65+

5%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $50

THOMAS BRANDECKER MD

Geriatric Medicine

5,801

$334K

294
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

ADRIAN VISOIU MD

Geriatric Medicine

3,489

$198K

246
239 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

ERIC RODRIGUEZ MD

Geriatric Medicine

1,974

$137K

129
122 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $50

JOEL BETESH MD

Geriatric Medicine

3,175

$164K

208
169 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

JOHN HARETOS M.D.

Geriatric Medicine

5,159

$390K

260
219 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $50

FRED RUBIN MD

Geriatric Medicine

6,316

$407K

300
295 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

SHADAB KALIM M.D.

Geriatric Medicine

3,980

$190K

260
92 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

GAINNEOS GOLDIE MD

Geriatric Medicine

17,711

$803K

858
820 are 65+

1%
patients receiving schedule two controlled substances

Avg: 14%

24%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

KAREN GARDNER D.O.

Geriatric Medicine

3,065

$185K

194
169 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

NICOLE OSEVALA M.D.

Geriatric Medicine

1,754

$102K

87
73 are 65+

22%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

JOHN MARCELIS MD

Geriatric Medicine

2,300

$148K

133
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

JAY KLOIN MD

Geriatric Medicine

1,283

$76.8K

60
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

BENJAMIN JOHN MD

Geriatric Medicine

569

$13.5K

96
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$24
Average prescription price

Avg: $50

ARMAND FORMICA DO

Geriatric Medicine

1,233

$49K

293
232 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank